Review: Percutaneous Cryoablation for Bone Tumors – Applications and Outcomes

Percutaneous cryoablation has emerged as a key minimally invasive, image-guided option for treating diverse bone tumors, ranging from benign lesions to painful metastases. By utilizing extreme cold to destroy pathological tissue, the procedure offers a targeted alternative for patients who are not suitable candidates for traditional surgical resection or radiation.

Minimally invasive image-guided interventions have gained increasing attention as complementary therapeutic approaches in musculoskeletal oncology, according to a review published in Cureus. While standard treatments like surgery and radiotherapy remain essential, they can cause serious side effects and require long recovery periods. Cryoablation provides a specialized alternative that allows clinicians to monitor the treatment zone in real time.

Precision Through Controlled Freezing

The procedure works by applying extremely low temperatures through percutaneous cryoprobes, often reaching below −100°C. These systems use argon gas expansion to create rapid cooling, which triggers cellular death through ice crystal formation, osmotic shifts, and membrane damage. Cureus reported that repeated freeze-thaw cycles are utilized to increase the extent of irreversible tissue necrosis.

Beyond direct cellular destruction, the technique induces microvascular injury that leads to secondary ischemic necrosis. Clinicians use CT or MRI to visualize the developing ice ball during the intervention. However, the visible boundary of this ice ball does not perfectly align with the lethal temperature zone, requiring surgeons to maintain an adequate safety margin to ensure complete tumor eradication.

Expanding Clinical Applications

Initially reserved for benign lesions and pain management in skeletal metastases, the scope of cryoablation has grown significantly. It is now considered for oligometastatic disease, locally recurrent tumors, and primary malignant bone lesions where surgery is not feasible. The treatment may also serve as an adjunct to surgery in selected cases, particularly for locally aggressive bone tumors, Cureus noted.

Success depends on careful patient selection and multidisciplinary planning involving radiologists and oncologists. Before starting, teams evaluate tumor histology, size, and proximity to sensitive structures like nerves or blood vessels. If the diagnosis is unclear or if there is a risk of pathological fracture, biopsy and structural stabilization are typically required before any ablation takes place.

Protection of Sensitive Anatomy

Protecting healthy tissue remains a priority, as the freezing process can inadvertently damage nerves, skin, or cartilage near the tumor site. Specialists use various protective techniques, such as hydrodissection, to create a buffer between the ice ball and vulnerable anatomical structures. Because the evidence remains heterogeneous, the specific protocol for probe placement and freezing duration is tailored to each patient’s unique clinical objectives.

Photo of author

Health Desk

Health Desk at Archyde.

Alan Milburn Proposes Decade-Long Overhaul as UK NEETs Near One Million